delinia

Celgene acquires autoimmune startup Delinia for $300M+

Celgene acquires autoimmune startup Delinia for $300M+

Celgene bought the startup for $300 million upfront to expand its inflammation and immunology pipeline with Delinia's regulatory T cell therapy.

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases

The company will develop new medicines to selectively potentiate and expand regulatory T cells.